CHRISTUS Coushatta Health Care Center
1635 Marvel St, Coushatta, LA · Christushealth · · NPI 1205824208
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Injection(s) trigger point(s) single/multiple >= 3 muscle(s) CPT 20553 | not published | not published | $649.24 – $649.24 | 1 |
| Injection, ticarcillin disod HCPCS S0040 | not published | not published | $14.40 – $14.40 | 1 |
| Injection torsemide 10 mg/ml HCPCS J3265 | not published | not published | $3.21 – $3.21 | 1 |
| Injection treatment of eye CPT 66020 | not published | not published | $349.65 – $5,097.04 | 8 |
| Injection treatment of eye CPT 66030 | not published | not published | $349.65 – $5,097.04 | 8 |
| Injection treatment of nerve CPT 64605 | not published | not published | $349.65 – $4,272.98 | 8 |
| Injection treatment of nerve CPT 64610 | not published | not published | $349.65 – $4,272.98 | 8 |
| Injection treatment of nose CPT 30200 | not published | not published | $1,220.13 – $1,220.13 | 1 |
| Inject sacroiliac joint CPT 27096 | not published | not published | $1,441.70 – $1,441.70 | 1 |
| Inject/treat eye socket CPT 67500 | not published | not published | $349.65 – $710.16 | 8 |
| Inject/treat eye socket CPT 67505 | not published | not published | $710.16 – $710.16 | 1 |
| Inject/treat eye socket CPT 67515 | not published | not published | $710.16 – $710.16 | 1 |
| Inj efgart-alfa 2mg hya-qvfc HCPCS J9334 | not published | not published | $35.12 – $35.12 | 1 |
| Inj eflapegrastim-xnst 0.1mg HCPCS J1449 | not published | not published | $27.74 – $27.74 | 1 |
| Inj., emapalumab-lzsg, 1 mg HCPCS J9210 | not published | not published | $413.63 – $413.63 | 1 |
| Inj., emicizumab-kxwh 0.5 mg HCPCS J7170 | not published | not published | $49.97 – $55.72 | 2 |
| Inj, epinephrine (belcher) HCPCS J0173 | not published | not published | $1.97 – $1.97 | 1 |
| Inj., eravacycline, 1 mg HCPCS J0122 | not published | not published | $1.12 – $1.28 | 2 |
| Inj, etelcalcetide, 0.1 mg HCPCS J0606 | not published | not published | $2.66 – $3.64 | 2 |
| Inj, eteplirsen, 10 mg HCPCS J1428 | not published | not published | $172.80 – $203.52 | 2 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $168.75 – $193.62 | 2 |
| Inj., evomela, 1 mg HCPCS J9246 | not published | not published | $15.96 – $43.20 | 2 |
| Inj, factor x, (human), 1iu HCPCS J7175 | not published | not published | $9.02 – $9.66 | 2 |
| Inj, faricimab-svoa, 0.1mg HCPCS J2777 | not published | not published | $36.91 – $36.91 | 1 |
| Inj fe-based mr contrast,1ml HCPCS Q9953 | not published | not published | $68.26 – $68.26 | 1 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $21.89 – $27.36 | 2 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $138.91 – $148.40 | 2 |
| Inj ferric pyrophosphate cit HCPCS J1443 | not published | not published | $0.04 – $0.04 | 2 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.17 – $1.20 | 2 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $7.75 – $7.75 | 1 |
| Inj follitropin alfa 75 iu HCPCS S0126 | not published | not published | $204.25 – $204.25 | 1 |
| Inj follitropin beta 75 iu HCPCS S0128 | not published | not published | $172.02 – $172.02 | 1 |
| Inj for mammo ductogram CPT 19030 | not published | not published | $616.36 – $616.36 | 1 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $2.16 – $2.16 | 1 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $628.34 – $728.38 | 2 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $1.97 – $3.04 | 2 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $13.00 – $13.00 | 1 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $22.47 – $22.47 | 1 |
| Inj, gadopiclenol, 1 ml HCPCS A9573 | not published | not published | $4.14 – $4.14 | 1 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $63.60 – $63.60 | 1 |
| Inj ganirelix acetat 250 mcg HCPCS S0132 | not published | not published | $185.17 – $185.17 | 1 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $8.25 – $8.25 | 1 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $106.87 – $119.02 | 2 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,869.01 – $2,869.01 | 1 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | not published | not published | $2.08 – $2.08 | 1 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $172.80 – $176.02 | 2 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $5.97 – $7.63 | 2 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $78.05 – $116.76 | 2 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $10.23 – $14.72 | 2 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,932,600.00 – $3,932,600.00 | 1 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $3.63 – $3.63 | 1 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $68.49 – $79.04 | 2 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $58.50 – $66.39 | 2 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.29 – $1.53 | 2 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $5.33 – $5.33 | 1 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $14.42 – $19.27 | 2 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $64.22 – $81.89 | 2 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $2.55 – $2.67 | 2 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $77.54 – $79.68 | 2 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.22 – $0.22 | 1 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $471.60 – $512.87 | 2 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $349.65 – $1,783.43 | 8 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $37.40 – $42.70 | 2 |
| Inj. insulin (fiasp) HCPCS J1812 | not published | not published | $2.04 – $2.04 | 1 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $448.26 – $448.26 | 1 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $448.26 – $448.26 | 1 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $13.28 – $13.28 | 1 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $48.93 – $51.59 | 2 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.82 – $1.82 | 1 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $1.94 – $2.59 | 2 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.34 – $1.56 | 2 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $2.26 – $2.26 | 1 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $80.07 – $109.02 | 2 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $44.88 – $44.88 | 1 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.42 – $1.42 | 1 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $0.76 – $0.79 | 2 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $23.24 – $23.24 | 1 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $23.17 – $32.37 | 2 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.02 – $0.10 | 2 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $2.82 – $2.82 | 1 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $6.14 – $6.14 | 1 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $15.20 – $15.20 | 1 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,483,160.00 – $3,483,160.00 | 1 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $314.23 – $337.60 | 2 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $24.79 – $25.73 | 2 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $2,900.20 – $2,900.20 | 1 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $3.38 – $3.99 | 2 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $164.65 – $229.25 | 2 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $549.85 – $549.85 | 1 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $820.23 – $820.23 | 1 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $210.48 – $210.48 | 1 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | not published | not published | $3.04 – $3.58 | 2 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $2.24 – $2.24 | 1 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $1.78 – $2.20 | 2 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $1.70 – $1.70 | 1 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $1.06 – $1.27 | 2 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.52 – $0.52 | 1 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $36.82 – $36.82 | 1 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $231.06 – $252.84 | 2 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $26.73 – $26.73 | 1 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.